Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Surveillance of Takecab Tablets for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"

NCT03214094 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03214094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03214094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Surveillance of Takecab Tablets for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
September 1, 2016
Completion date
February 28, 2019
Enrollment
1,119 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric or duodenal ulcers